[HTML][HTML] Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy

M Chehelgerdi, F Behdarvand Dehkordi… - Molecular Cancer, 2023 - Springer
The advent of iPSCs has brought about a significant transformation in stem cell research,
opening up promising avenues for advancing cancer treatment. The formation of cancer is a …

[HTML][HTML] The role of organoids in cancer research

Z Fang, P Li, F Du, L Shang, L Li - Experimental Hematology & Oncology, 2023 - Springer
Organoids are established through in vitro 3D culture, and they can mimic the structure and
physiological functions of organs or tissues in vivo. Organoids have attracted much attention …

[HTML][HTML] The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis

S Guo, J Huang, G Li, W Chen, Z Li, J Lei - Molecular Cancer, 2023 - Springer
Current research has demonstrated that extracellular vesicles (EVs) and circulating tumor
cells (CTCs) are very closely related in the process of distant tumor metastasis. Primary …

Beyond extracellular vesicles: hybrid membrane nanovesicles as emerging advanced tools for biomedical applications

M Sun, J Yang, Y Fan, Y Zhang, J Sun, M Hu… - Advanced …, 2023 - Wiley Online Library
Extracellular vesicles (EVs), involved in essential physiological and pathological processes
of the organism, have emerged as powerful tools for disease treatment owing to their unique …

Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients

D Khorsandi, JW Yang, S Foster… - Advanced …, 2024 - Wiley Online Library
Patient‐derived organoids (PDOs) developed ex vivo and in vitro are increasingly used for
therapeutic screening. They provide a more physiologically relevant model for drug …

Development of antibody‐drug conjugates in cancer: Overview and prospects

DY Ruan, HX Wu, Q Meng, RH Xu - Cancer Communications, 2024 - Wiley Online Library
In recent years, remarkable breakthroughs have been reported on antibody‐drug
conjugates (ADCs), with 15 ADCs successfully entering the market over the past decade …

[HTML][HTML] Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression

W Jiang, G Gu, Y Zhang, Y Song, M Shi, G Wang… - Pharmacological …, 2023 - Elsevier
The design of chimeric antigen receptors (CAR) significantly enhances the antitumor efficacy
of T cells. Although some CAR-T products have been approved by FDA in treating …

Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy

B Zhang, J Shi, X Shi, X Xu, L Gao, S Li, M Liu… - Drug Resistance …, 2024 - Elsevier
The treatment for trastuzumab-resistant breast cancer (BC) remains a challenge in clinical
settings. It was known that CD47 is preferentially upregulated in HER2+ BC cells, which is …

The role of extracellular vesicles in the treatment of prostate cancer

C Hu, Q Chen, T Wu, X Du, Y Dong, Z Peng, W Xue… - Small, 2024 - Wiley Online Library
Prostate cancer (PCa) has become a public health concern in elderly men due to an ever‐
increasing number of estimated cases. Unfortunately, the available treatments are …

Pancreatic cancer environment: from patient-derived models to single-cell omics

A Gu, J Li, S Qiu, S Hao, ZY Yue, S Zhai, MY Li… - Molecular …, 2024 - pubs.rsc.org
Pancreatic cancer (PC) is a highly malignant cancer characterized by poor prognosis, high
heterogeneity, and intricate heterocellular system. Selecting an appropriate experimental …